Extending combination therapy with peginterferon alfa-2b plus ribavirin for genotype 1 chronic hepatitis C late responders: A report of 9 cases
Author:
Publisher
Wiley
Subject
Hepatology
Reference7 articles.
1. EASL International Consensus Conference on Hepatitis C Paris, 26–28 February 1999
2. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial
3. Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection
4. High-Throughput Real-Time Reverse Transcription-PCR Quantitation of Hepatitis C Virus RNA
Cited by 56 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Interleukin 28B polymorphism predicts interferon plus ribavirin treatment outcome in patients with hepatitis C virus-related liver cirrhosis: A multicenter retrospective study in Japan;Hepatology Research;2014-01-09
2. Role of different regions of the hepatitis C virus genome in the therapeutic response to interferon-based treatment;Archives of Virology;2013-07-13
3. Extended peginterferon plus ribavirin treatment for 72 weeks versus standard peginterferon plus ribavirin treatment for 48 weeks in chronic hepatitis C genotype 1 infected slow-responder adult patients;Cochrane Database of Systematic Reviews;2012-09-12
4. Association of IL28B genotype and viral response of hepatitis C virus genotype 2 to interferon plus ribavirin combination therapy;Journal of Medical Virology;2012-08-15
5. Management of hepatitis C in HIV and/or HBV co-infected patients;Best Practice & Research Clinical Gastroenterology;2012-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3